Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review
暂无分享,去创建一个
D. Dmitrenko | V. Kalinin | A. A. Usoltseva | N. Utyashev | E. E. Timechko | A. I. Paramonova | Alexey M. Yakimov | Nikita Ivin | Anna A. Utyasheva | Albina V. Yakunina | Alexey M Yakimov | Albina V Yakunina
[1] C. Li,et al. The Study of Overexpression of Peroxiredoxin-2 Reduces MPP+-Induced Toxicity in the Cell Model of Parkinson’s Disease , 2023, Neurochemical Research.
[2] D. Dmitrenko,et al. Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults , 2023, Metabolites.
[3] Daniel W. Summers,et al. Membrane association is required for Stmn2-mediated axon protection , 2022, bioRxiv.
[4] J. Boice,et al. Radiation and CNS effects: summary of evidence from a recent symposium of the Radiation Research Society , 2022, International journal of radiation biology.
[5] M. Ropacka-Lesiak,et al. Blood-Brain Barrier Disintegration in Growth-Restricted Fetuses with Brain Sparing Effect , 2022, International journal of molecular sciences.
[6] G. Žoldák,et al. Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells , 2022, International journal of molecular sciences.
[7] Jing Ding,et al. Neuropilin-2 Signaling Modulates Mossy Fiber Sprouting by Regulating Axon Collateral Formation Through CRMP2 in a Rat Model of Epilepsy , 2022, Molecular Neurobiology.
[8] Ye Lin,et al. Retinal neurodegeneration in a mouse model of green-light-induced myopia. , 2022, Experimental eye research.
[9] Zhao Wang,et al. Proteomic Analysis Reveals the Vital Role of Synaptic Plasticity in the Pathogenesis of Temporal Lobe Epilepsy , 2022, Neural plasticity.
[10] A. Hosseini,et al. The role of astrocytes in epileptic disorders , 2022, Physiological reports.
[11] S. Bhatia,et al. Polyphenols inhibiting MAPK signalling pathway mediated oxidative stress and inflammation in depression. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] K. Kuter,et al. Beyond the GFAP-Astrocyte Protein Markers in the Brain , 2021, Biomolecules.
[13] R. Franklin,et al. Diversity of Reactive Astrogliosis in CNS Pathology: Heterogeneity or Plasticity? , 2021, Frontiers in Cellular Neuroscience.
[14] P. Hartikainen,et al. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[15] G. He,et al. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma , 2021, World Journal of Surgical Oncology.
[16] K. Park,et al. Temporal lobe epilepsy with or without hippocampal sclerosis: Structural and functional connectivity using advanced MRI techniques , 2021, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[17] K. Gardiner,et al. Altered Protein Profiles During Epileptogenesis in the Pilocarpine Mouse Model of Temporal Lobe Epilepsy , 2021, Frontiers in Neurology.
[18] M. Çalık,et al. Investigation on Acute Phase Reactants and Oxidant - Antioxidant Parameters in Patients Diagnosed as Having Generalized Tonic Clonic Type Epilepsy on Antiepileptic Monotherapy and Polytherapy , 2021 .
[19] E. Kumlien,et al. Quantitative proteomic analysis to identify differentially expressed proteins in patients with epilepsy , 2021, Epilepsy Research.
[20] K. Khajeh,et al. Proteomic profiling of the rat hippocampus from the kindling and pilocarpine models of epilepsy: potential targets in calcium regulatory network , 2021, Scientific Reports.
[21] H. Potter,et al. Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease , 2021, Neurobiology of Aging.
[22] Li Feng,et al. iTRAQ-Based Proteomic Analysis of Dentate Gyrus in Temporal Lobe Epilepsy With Hippocampal Sclerosis , 2021, Frontiers in Neurology.
[23] V. Lennon,et al. The complement C3‐C3aR pathway mediates microglia–astrocyte interaction following status epilepticus , 2020, Glia.
[24] Chen Zhang,et al. iTRAQ‐based proteomic analysis of the hippocampus of pentylenetetrazole‐kindled epileptic rats , 2020, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience.
[25] M. Movahedi,et al. Identification of Serum Biomarkers for Differentiating Epileptic Seizures from Psychogenic Attacks Using a Proteomic Approach; a Comparative study , 2020, Archives of academic emergency medicine.
[26] Tiechao Jiang,et al. TMT-Based Proteomic Analysis of Plasma from Children with Rolandic Epilepsy , 2020, Disease markers.
[27] X. Bao,et al. Proteomic profiling of sclerotic hippocampus revealed dysregulated packaging of vesicular neurotransmitters in temporal lobe epilepsy , 2020, Epilepsy Research.
[28] M. Sabbagh,et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease , 2020, Neurology.
[29] K. Fukuchi,et al. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease , 2020, Frontiers in Immunology.
[30] G. O’Keeffe,et al. STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5 , 2020, iScience.
[31] S. Sisodiya,et al. Granule Cell Dispersion in Human Temporal Lobe Epilepsy: Proteomics Investigation of Neurodevelopmental Migratory Pathways , 2020, Frontiers in Cellular Neuroscience.
[32] M. Bartos,et al. Dentate gyrus circuits for encoding, retrieval and discrimination of episodic memories , 2020, Nature Reviews Neuroscience.
[33] F. Pallardó,et al. Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age , 2019, Molecular Neurobiology.
[34] C. Taghibiglou,et al. Nuclear accumulation of GAPDH, GluA2 and p53 in post-mortem substantia nigral region of patients with Parkinson’s disease , 2019, Neuroscience Letters.
[35] F. Onat,et al. Relationships between astrocytes and absence epilepsy in rat: An experimental study , 2019, Neuroscience Letters.
[36] C. Rodrigues,et al. Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease , 2019, Cell Death & Disease.
[37] W. Swardfager,et al. The complement cascade in Alzheimer’s disease: a systematic review and meta-analysis , 2019, Molecular Psychiatry.
[38] C. Subhramanyam,et al. Microglia-mediated neuroinflammation in neurodegenerative diseases. , 2019, Seminars in cell & developmental biology.
[39] Joseph S. Briguglio,et al. Synaptotagmin 1 clamps synaptic vesicle fusion in mammalian neurons independent of complexin , 2019, Nature Communications.
[40] V. Vorobyov,et al. Detrimental and synergistic role of epilepsy – Alzheimer’s disease risk factors , 2019, Neural regeneration research.
[41] J. Tepper,et al. Neuropilin 2 Signaling Mediates Corticostriatal Transmission, Spine Maintenance, and Goal-Directed Learning in Mice , 2019, The Journal of Neuroscience.
[42] A. Falcão,et al. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches. , 2019, Pharmacological research.
[43] A. Das. Disease association of human tumor suppressor genes , 2019, Molecular Genetics and Genomics.
[44] J. Sander,et al. Epilepsy in adults , 2019, The Lancet.
[45] I. Jialal,et al. Physiology, Acute Phase Reactants , 2019 .
[46] D. Reddy,et al. Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy , 2019, International journal of molecular sciences.
[47] N. Fitz,et al. The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives , 2018, International journal of molecular sciences.
[48] Simone Lista,et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic , 2018, Nature Reviews Neurology.
[49] J. Kassubek,et al. Serum GFAP as a biomarker for disease severity in multiple sclerosis , 2018, Scientific Reports.
[50] E. Yacubian,et al. Altered Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy , 2018, Pharmaceuticals.
[51] Ingo Borggraefe,et al. SYT1-associated neurodevelopmental disorder: a case series , 2018, Brain : a journal of neurology.
[52] A. Ikeda,et al. Antiepileptic Drugs Elevate Astrocytic Kir4.1 Expression in the Rat Limbic Region , 2018, Front. Pharmacol..
[53] K. Hamandi,et al. Complement system biomarkers in epilepsy , 2018, Seizure.
[54] J. Loeb,et al. Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions , 2018, PloS one.
[55] Y. Fujii,et al. Pathophysiological Characteristics Associated With Epileptogenesis in Human Hippocampal Sclerosis , 2018, EBioMedicine.
[56] A. Becker,et al. Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis , 2018, Neuropathology and applied neurobiology.
[57] V. Cavaliere,et al. Extracellular NME proteins: a player or a bystander? , 2018, Laboratory Investigation.
[58] Hui Shen,et al. The antiepileptic drug levetiracetam promotes neuroblast differentiation and expression of superoxide dismutase in the mouse hippocampal dentate gyrus via PI3K/Akt signalling , 2018, Neuroscience Letters.
[59] M. Nadai,et al. Effect of carbamazepine on expression of UDP-glucuronosyltransferase 1A6 and 1A7 in rat brain. , 2017, Drug metabolism and pharmacokinetics.
[60] Linda J. C. van Waalwijk van Doorn,et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry , 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[61] R. Kukreti,et al. In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2 , 2017, Molecules.
[62] A. Abdel-Moneim,et al. Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats , 2017, Metabolic Brain Disease.
[63] Ben C. Collins,et al. Quantitative proteomics: challenges and opportunities in basic and applied research , 2017, Nature Protocols.
[64] R. Krause,et al. A systems level analysis of epileptogenesis-associated proteome alterations , 2017, Neurobiology of Disease.
[65] O. Firuzi,et al. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope? , 2017, Current drug targets.
[66] Hui Yang,et al. Differentially expressed proteins underlying childhood cortical dysplasia with epilepsy identified by iTRAQ proteomic profiling , 2017, PloS one.
[67] K. Blennow,et al. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.
[68] R. Aebersold,et al. On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.
[69] A. Vlahou,et al. High-Throughput LC-MS/MS Proteomic Analysis of a Mouse Model of Mesiotemporal Lobe Epilepsy Predicts Microglial Activation Underlying Disease Development. , 2016, Journal of proteome research.
[70] A. Vezzani,et al. Proteomic profiling of epileptogenesis in a rat model: Focus on inflammation , 2016, Brain, Behavior, and Immunity.
[71] Xia Zhang,et al. Role of neuroinflammation in neurodegenerative diseases (Review) , 2016, Molecular medicine reports.
[72] M. Disatnik,et al. Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington’s disease , 2015, EMBO molecular medicine.
[73] Kimberly J. Jenko,et al. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein. , 2015, JAMA neurology.
[74] K. Staley. Molecular mechanisms of epilepsy , 2015, Nature Neuroscience.
[75] I. Fournier,et al. Human temporal lobe epilepsy analyses by tissue proteomics , 2014, Hippocampus.
[76] E. Cavalheiro,et al. Decreased expression of proteins involved in energy metabolism in the hippocampal granular layer of rats submitted to the pilocarpine epilepsy model , 2014, Neuroscience Letters.
[77] D. Janigro,et al. Inflammatory pathways of seizure disorders , 2014, Trends in Neurosciences.
[78] G. Biagini,et al. Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic? , 2014, Current medicinal chemistry.
[79] H. Tanaka,et al. Phosphorylation of Dpsyl2 (CRMP2) and Dpsyl3 (CRMP4) is required for positioning of caudal primary motor neurons in the zebrafish spinal cord , 2013, Developmental neurobiology.
[80] T. Südhof,et al. Neurotransmitter Release: The Last Millisecond in the Life of a Synaptic Vesicle , 2013, Neuron.
[81] A. Vezzani,et al. Immunity Activation in Brain Cells in Epilepsy: Mechanistic Insights and Pathological Consequences , 2013, Neuropediatrics.
[82] L. Hillered,et al. Identification of Injury Specific Proteins in a Cell Culture Model of Traumatic Brain Injury , 2013, PloS one.
[83] E. Hol,et al. GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease , 2012, PloS one.
[84] M. Fukata,et al. Leucine‐rich glioma inactivated 1 (Lgi1), an epilepsy‐related secreted protein, has a nuclear localization signal and localizes to both the cytoplasm and the nucleus of the caudal ganglionic eminence neurons , 2012, The European journal of neuroscience.
[85] D. Macêdo,et al. Oxidative Stress and Epilepsy: Literature Review , 2012, Oxidative medicine and cellular longevity.
[86] E. Chapman,et al. Uncoupling the roles of synaptotagmin I as a dual Ca2+ sensor during endo- and exocytosis of synaptic vesicles , 2011, Nature Neuroscience.
[87] A. Pitkänen,et al. Mechanisms of epileptogenesis and potential treatment targets , 2011, The Lancet Neurology.
[88] P. Horn,et al. Evaluating reference genes to normalize gene expression in human epileptogenic brain tissues. , 2010, Biochemical and biophysical research communications.
[89] Maria Thom,et al. Reliability of patterns of hippocampal sclerosis as predictors of postsurgical outcome , 2010, Epilepsia.
[90] R. Huganir,et al. Secreted Semaphorins Control Spine Distribution and Morphogenesis in the Postnatal CNS , 2009, Nature.
[91] Yuquan Wei,et al. A review of current applications of mass spectrometry for neuroproteomics in epilepsy. , 2009, Mass spectrometry reviews.
[92] E. Blalock,et al. Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: Implications for autism and epilepsy , 2009, Epilepsia.
[93] Pat Levitt,et al. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. , 2009, The Journal of clinical investigation.
[94] Jie Yuan,et al. Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy , 2009, Brain Research.
[95] Ying Zhang,et al. Comparative Proteomics and Correlated Signaling Network of Rat Hippocampus in the Pilocarpine Model of Temporal Lobe Epilepsy , 2007 .
[96] Jens M. Rick,et al. Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.
[97] F. L. D. Silva,et al. Complement activation in experimental and human temporal lobe epilepsy , 2007, Neurobiology of Disease.
[98] Lin-Tao Zhou,et al. Febrile seizures are associated with mutation of seizure‐related (SEZ) 6, a brain‐specific gene , 2007, Journal of neuroscience research.
[99] Wei Yang,et al. Proteomic analysis and comparison of the biopsy and autopsy specimen of human brain temporal lobe , 2006, Proteomics.
[100] C. Baumgartner,et al. Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy , 2006, Amino Acids.
[101] R. Cumming,et al. Amyloid‐β induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease , 2005 .
[102] Andrey Rzhetsky,et al. Emergent behavior of growing knowledge about molecular interactions , 2005, Nature Biotechnology.
[103] M. Mann,et al. Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.
[104] G. Cascino. Temporal Lobe Epilepsy: More than Hippocampal Pathology , 2005, Epilepsy currents.
[105] S. Snyder,et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding , 2005, Nature Cell Biology.
[106] P. Lescuyer,et al. Identification of post‐mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration , 2004, Proteomics.
[107] Y. Kwak,et al. Proteomic analysis of human cerebral cortex in epileptic patients , 2004, Experimental & Molecular Medicine.
[108] Maria Helena Pimentel,et al. Comparative , 1986, American Political Science Review.
[109] Thomas Bourgeron,et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.
[110] H. Haapasalo,et al. Expression of Antioxidant Enzymes in Astrocytic Brain Tumors , 2003, Brain pathology.
[111] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[112] N. Anderson,et al. The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.
[113] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[114] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.
[115] C. Dodia,et al. 1-Cys Peroxiredoxin, a Bifunctional Enzyme with Glutathione Peroxidase and Phospholipase A2 Activities* , 2000, The Journal of Biological Chemistry.
[116] T. Babb,et al. The pathogenic and progressive features of chronic human hippocampal epilepsy , 1996, Epilepsy Research.
[117] T L Babb,et al. Influence of the type of initial precipitating injury and at what age it occurs on course and outcome in patients with temporal lobe seizures. , 1995, Journal of neurosurgery.
[118] Yan Zhang,et al. Acute phase reactant serum amyloid A in inflammation and other diseases. , 2019, Advances in clinical chemistry.
[119] P. Meleady. Two-Dimensional Gel Electrophoresis and 2D-DIGE. , 2018, Methods in molecular biology.
[120] A. Blom,et al. C4b-binding protein: The good, the bad and the deadly. Novel functions of an old friend. , 2016, Immunology letters.
[121] L. Paša-Tolić,et al. High-throughput proteomics. , 2014, Annual review of analytical chemistry.
[122] E. Cavalheiro,et al. Granule cell dispersion is not a predictor of surgical outcome in temporal lobe epilepsy with mesial temporal sclerosis. , 2013, Clinical neuropathology.
[123] A. Kiliçarslan,et al. Acute Phase Reactants , 2013 .
[124] J. Clelland. Genomics, proteomics, and the nervous system , 2011 .
[125] D. Sizova. Protein Expression Profile of Alzheimer’s Disease Mouse Model Generated by Difference Gel Electrophoresis (DIGE) Approach , 2011 .
[126] D. Tomassoni,et al. Biomarkers of glial cell proliferation and differentiation in culture. , 2010, Frontiers in bioscience.
[127] R. Pumain,et al. A key glycolytic enzyme plays a dual role in GABAergic neurotransmission and in human epilepsy. , 2006, Critical Reviews in Neurobiology.
[128] S. Patterson. How Much of the Proteome Do We See with Discovery-Based Proteomics Methods and How Much Do We Need to See? , 2004 .